Skip to content

Application of transcutaneous vagus nerve electrical stimulation in autonomic dysfunction

Application of transcutaneous vagus nerve electrical stimulation in autonomic dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123804
Enrollment
Unknown
Registered
2026-04-30
Start date
2026-05-10
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Various neurological and systemic diseases can lead to autonomic dysfunction, which in turn triggers a series of clinical symptoms. For example, patients with Parkinson's disease often experience autonomic dysfunctions such as constipation, urinary disturbances, and orthostatic hypotension

Interventions

Sham Group:Sham transcutaneous auricular vagus nerve stimulation

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.age: 18–80 years; 2.presence of clinical symptoms related to autonomic dysfunction, including at least one of the following: palpitations, orthostatic intolerance, fatigue, sleep disturbances, gastrointestinal dysfunction, or chronic pain accompanied by signs of autonomic imbalance; 3.autonomic function assessment indicates functional abnormalities, such as reduced heart rate variability, abnormal tilt test results, or other objective or semi-objective evaluations supporting autonomic dysfunction; 4.voluntary acceptance of transauricular vagus nerve electrical stimulation treatment and signing of an informed consent form.

Exclusion criteria

Exclusion criteria: 1.individuals with unstable physical conditions, such as severe pulmonary and cardiac diseases, liver or kidney failure, or a history of malignant tumors; 2.those with implanted pacemakers, implantable cardioverter-defibrillators, or other internal electrical stimulation devices; 3.those with severe organic autonomic neuropathy who are unsuitable for neuroregulation therapy during the rehabilitation phase; 4.those with local infections, damage, or skin lesions on the auricle that prevent electrical stimulation; 5.individuals with severe mental disorders, cognitive impairments, or who cannot cooperate with treatment and assessment; 6.those who are pregnant or otherwise assessed as unsuitable for electrical stimulation therapy; 7.individuals with a heart rate below 60 beats per minute.

Design outcomes

Primary

MeasureTime frame
Sleep Disorder Assessment;Pain Assessment;Emotion;Constipation Functional Assessment;

Secondary

MeasureTime frame
Mechanism evaluation;

Countries

China

Contacts

Public ContactPeijia Jing

West China Hospital of Sichuan University

82323125@qq.com+86 28 85425709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026